ID23443A - Turunan tiadiazolil piridazin penghambat angiogenesis - Google Patents
Turunan tiadiazolil piridazin penghambat angiogenesisInfo
- Publication number
- ID23443A ID23443A IDW991664A ID991664A ID23443A ID 23443 A ID23443 A ID 23443A ID W991664 A IDW991664 A ID W991664A ID 991664 A ID991664 A ID 991664A ID 23443 A ID23443 A ID 23443A
- Authority
- ID
- Indonesia
- Prior art keywords
- alk
- 6alkyl
- hydrogen
- het
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
- C07D241/28—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Paper (AREA)
- Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
- Lubricants (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201930 | 1997-06-24 | ||
US5219497P | 1997-07-10 | 1997-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID23443A true ID23443A (id) | 2000-04-20 |
Family
ID=8228477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991664A ID23443A (id) | 1997-06-24 | 1998-06-22 | Turunan tiadiazolil piridazin penghambat angiogenesis |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0991649B1 (id) |
JP (1) | JP2002512630A (id) |
CN (1) | CN1198822C (id) |
AT (1) | ATE235489T1 (id) |
AU (1) | AU732129B2 (id) |
BR (1) | BR9810321A (id) |
CA (1) | CA2294551A1 (id) |
CZ (1) | CZ296000B6 (id) |
DE (1) | DE69812623T2 (id) |
DK (1) | DK0991649T3 (id) |
EE (1) | EE03828B1 (id) |
ES (1) | ES2195374T3 (id) |
HU (1) | HU225154B1 (id) |
ID (1) | ID23443A (id) |
IL (1) | IL133652A (id) |
MY (1) | MY120046A (id) |
NZ (1) | NZ501649A (id) |
PL (1) | PL191409B1 (id) |
PT (1) | PT991649E (id) |
RU (1) | RU2194049C2 (id) |
SK (1) | SK283705B6 (id) |
TR (1) | TR199902955T2 (id) |
WO (1) | WO1998058929A1 (id) |
ZA (1) | ZA985467B (id) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689883B1 (en) | 1999-09-28 | 2004-02-10 | Bayer Pharmaceuticals Corporation | Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
US7977333B2 (en) | 2000-04-20 | 2011-07-12 | Bayer Healthcare Llc | Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
US6903101B1 (en) | 2000-08-10 | 2005-06-07 | Bayer Pharmaceuticals Corporation | Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
WO2008128335A1 (en) * | 2007-04-20 | 2008-10-30 | Merck Frosst Canada Ltd. | Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
US9102669B2 (en) | 2011-12-06 | 2015-08-11 | Janssen Pharmaceutica Nv | Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors |
WO2013085954A1 (en) | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
GB201311953D0 (en) * | 2013-07-03 | 2013-08-14 | Redx Pharma Ltd | Compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6339868A (ja) * | 1986-08-04 | 1988-02-20 | Otsuka Pharmaceut Factory Inc | ジ低級アルキルフエノ−ル誘導体 |
WO1997026258A1 (en) * | 1996-01-15 | 1997-07-24 | Janssen Pharmaceutica N.V. | Angiogenesis inhibiting pyridazinamines |
-
1998
- 1998-06-22 JP JP50381999A patent/JP2002512630A/ja not_active Ceased
- 1998-06-22 HU HU0004457A patent/HU225154B1/hu not_active IP Right Cessation
- 1998-06-22 TR TR1999/02955T patent/TR199902955T2/xx unknown
- 1998-06-22 WO PCT/EP1998/004021 patent/WO1998058929A1/en active IP Right Grant
- 1998-06-22 AU AU88537/98A patent/AU732129B2/en not_active Ceased
- 1998-06-22 DE DE69812623T patent/DE69812623T2/de not_active Expired - Fee Related
- 1998-06-22 PT PT98940098T patent/PT991649E/pt unknown
- 1998-06-22 ID IDW991664A patent/ID23443A/id unknown
- 1998-06-22 IL IL13365298A patent/IL133652A/xx not_active IP Right Cessation
- 1998-06-22 BR BR9810321-0A patent/BR9810321A/pt not_active Application Discontinuation
- 1998-06-22 EE EEP199900591A patent/EE03828B1/xx not_active IP Right Cessation
- 1998-06-22 DK DK98940098T patent/DK0991649T3/da active
- 1998-06-22 PL PL337657A patent/PL191409B1/pl not_active IP Right Cessation
- 1998-06-22 EP EP98940098A patent/EP0991649B1/en not_active Expired - Lifetime
- 1998-06-22 MY MYPI98002818A patent/MY120046A/en unknown
- 1998-06-22 ES ES98940098T patent/ES2195374T3/es not_active Expired - Lifetime
- 1998-06-22 AT AT98940098T patent/ATE235489T1/de not_active IP Right Cessation
- 1998-06-22 CZ CZ19994508A patent/CZ296000B6/cs not_active IP Right Cessation
- 1998-06-22 RU RU2000101868/04A patent/RU2194049C2/ru not_active IP Right Cessation
- 1998-06-22 SK SK1769-99A patent/SK283705B6/sk unknown
- 1998-06-22 CN CNB988064804A patent/CN1198822C/zh not_active Expired - Fee Related
- 1998-06-22 NZ NZ501649A patent/NZ501649A/en unknown
- 1998-06-22 CA CA002294551A patent/CA2294551A1/en not_active Abandoned
- 1998-06-23 ZA ZA9805467A patent/ZA985467B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2294551A1 (en) | 1998-12-30 |
WO1998058929A1 (en) | 1998-12-30 |
IL133652A (en) | 2003-04-10 |
SK283705B6 (sk) | 2003-12-02 |
DE69812623T2 (de) | 2004-02-19 |
EP0991649A1 (en) | 2000-04-12 |
JP2002512630A (ja) | 2002-04-23 |
SK176999A3 (en) | 2000-09-12 |
PL191409B1 (pl) | 2006-05-31 |
DE69812623D1 (de) | 2003-04-30 |
CZ296000B6 (cs) | 2005-12-14 |
EE03828B1 (et) | 2002-08-15 |
HU225154B1 (en) | 2006-07-28 |
RU2194049C2 (ru) | 2002-12-10 |
BR9810321A (pt) | 2000-09-05 |
ATE235489T1 (de) | 2003-04-15 |
TR199902955T2 (xx) | 2000-06-21 |
HUP0004457A2 (hu) | 2002-02-28 |
CN1261364A (zh) | 2000-07-26 |
HUP0004457A3 (en) | 2002-03-28 |
EP0991649B1 (en) | 2003-03-26 |
IL133652A0 (en) | 2001-04-30 |
CN1198822C (zh) | 2005-04-27 |
AU732129B2 (en) | 2001-04-12 |
ZA985467B (en) | 1999-12-23 |
PT991649E (pt) | 2003-08-29 |
AU8853798A (en) | 1999-01-04 |
PL337657A1 (en) | 2000-08-28 |
DK0991649T3 (da) | 2003-07-21 |
CZ450899A3 (cs) | 2000-08-16 |
EE9900591A (et) | 2000-08-15 |
MY120046A (en) | 2005-08-30 |
ES2195374T3 (es) | 2003-12-01 |
NZ501649A (en) | 2001-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE203534T1 (de) | Angiogenesis hemmende pyridazinamine | |
DK1119567T3 (da) | Quinazolinderivater | |
CA2272291A1 (en) | Crf antagonistic quino- and quinazolines | |
HU229576B1 (en) | Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same | |
RS52225B (en) | SYNERGETIC HERBICIDE PROCEDURES AND MIXTURES | |
ID23443A (id) | Turunan tiadiazolil piridazin penghambat angiogenesis | |
PL337649A1 (en) | Angiogenesis inhibiting derivatives of 5-substituted 1,2,4-thiadiazolyl | |
NO20000114D0 (no) | 2,4,4-trisubstituerte-1,3-diokolan-antifungale midler | |
JP2508681B2 (ja) | 除草剤組成物 | |
JPS61204106A (ja) | 除草剤クロロアセトアミド類 |